Vorsitz: A. Pott (Lingen), A. Schade (Erfurt)
| (V445) | Quantitative and qualitative assessment of left atrial cardiomyopathy using machine learning | |
| M. Bock, R. Tanacli, A. Alogna, G. Hindricks, J.-H. Gerds-Li, F. Hohendanner (Berlin) | ||
| Diskussion | ||
| (V446) | Echocardiographic characterization of invasively defined atrial cardiomyopathy: Results from multipolar high-density contact mapping | |
| M. T. Huttelmaier, C. Morbach, J. Albert, J. Herting, S. Störk, S. Frantz, T. H. Fischer (Würzburg) | ||
| Diskussion | ||
| (V447) | Prevalence of HFpEF in patients referred for atrial fibrillation ablation: Applying HFA-PEFF, H2FPEF, ESC 2021, and DELIVER to a TRUST snapshot data set | |
| J. Rieß, J. Obergassel, N. Pohlmann, M. Nies, L. Rottner, M. Lemoine, I. My, J. Wenzel, S. Kany, F. Moser, C. Pauschinger, D. Ismaili, B. Reißmann, F. Ouyang, C. Magnussen, C. Sinning, A. Metzner, P. Kirchhof, A. Rillig, für die Studiengruppe: TRUST (Hamburg) | ||
| Diskussion | ||
| (V448) | Time couse evaluation on management and outcome of oesophageal fistula formation following atrial fibrillation catheter ablation: A POTTER-AF sub-study | |
| C.-H. Heeger, V. Schmidt, H. Pürerfellner, S. Ș. Popescu, E. Gandjbakhch, P. Jais, P. Sommer, C. Sohns, K.-H. Kuck, J. L. Merino, A. Keelani, R. R. Tilz, für die Studiengruppe: POTTER-AF (Lübeck, Bad Oeynhausen, Hamburg, Bad Berka; Linz, AT; Paris, Bordeaux, FR; Madrid, ES) | ||
| Diskussion | ||
| (V449) | Both CHA2DS2VASc-Score and age are important and simple predictors for complications following left-atrial ablation procedures | |
| J. Obergassel, M. Remmel, C. Al-Taie, S. Taraba, M. Lemoine, L. Rottner, J. Rieß, M. Nies, S. Kany, I. My, J. Wenzel, B. Reißmann, F. Ouyang, A. Metzner, P. Kirchhof, A. Rillig (Hamburg) | ||
| Diskussion | ||
| (V450) | Safety of TEE omission for intracardiac thrombus exclusion before PVI | |
| M. Rothe, A. Böhmer, S. E. Nußbaum, L. Wiedenmann, K. Schneider, P. Spork, B.-C. Dobre, B. Kaess, J. Ehrlich (Wiesbaden) | ||
| Diskussion | ||
| (V451) | Is uninterrupted oral anticoagulation safe in patients with CKD undergoing left atrial catheter ablation? A comparison between uninterrupted direct oral anticoagulants and phenprocoumon administration | |
| N. Erhard, F. Bahlke, A. Tunsch-Martinez, F. Englert, M.-A. Popa, S. Lengauer, M. Telishevska, H. Krafft, F. Bourier, T. Reents, C. Lennerz, G. Heßling, I. Deisenhofer, M. Kottmaier (München, Neusäß) | ||
| Diskussion | ||
| (V452) | Role of cardiac biomarkers in addition to score-based risk stratification in patients with atrial fibrillation | |
| D. L. Qian, J. Dürr, K. Haas, C. Salbach, M. Yildirim, M. Biener, B. R. Milles, N. Frey, E. Giannitsis (Heidelberg) | ||
| Diskussion | ||
| (V453) | Comparison of periprocedural analgosedation in patients undergoing pulsed field ablation or cryoballoon ablation for atrial fibrillation | |
| R. Wahedi, S. Willems, M. Jularic, J. Hartmann, O. Anwar, J. Dickow, T. Harloff, M. A. Gunawardene (Hamburg) | ||
| Diskussion |